Structures and mechanism for the design of highly potent glucocorticoids

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cell Research

• Publication date

  2014-04-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/cr.2014.52PMID 24763108PMCID PMC4042175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucocorticoids.

  2011cited by this paper
• A Tale of Two Stomata

  2011cited by this paper
• Identification of a Lysosomal Pathway That Modulates Glucocorticoid Signaling and the Inflammatory Response

  2011cited by this paper
• Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis

  2010cited by this paper
• Glucocorticoid resistance in inflammatory diseases.

  2009cited by this paper
• The role of Dickkopf-1 in bone development, homeostasis, and disease.

  2009cited by this paper
• X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain.

  2008cited by this paper
• What goes on behind closed doors: physiological versus pharmacological steroid hormone actions

  2008cited by this paper
• Mometasone furoate: a review of its intranasal use in allergic rhinitis.

  2008cited by this paper
• Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis

  2008cited by this paper
• Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate

  2007cited by this paper
• Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol

  2007cited by this paper
• Inhaled mometasone furoate: A review of its use in persistent asthma in adults and adolescents.

  2006cited by this paper
• How much is enough? Modulation of dose-response curve for steroid receptor-regulated gene expression by changing concentrations of transcription factor.

  2006cited by this paper
• The search for safer glucocorticoid receptor ligands.

  2005cited by this paper
• Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension

  2004cited by this paper
• Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus.

  2004cited by this paper
• The importance of being varied in steroid receptor transactivation.

  2003cited by this paper
• The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression.

  2003cited by this paper
• The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain

  2003cited by this paper
• Glucocorticoid resistance in childhood leukaemia: mechanisms and modulation

  2003cited by this paper
• Mechanisms involved in the side effects of glucocorticoids.

  2002cited by this paper
• Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.

  2002cited by this paper
• The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression.

  2001cited by this paper
• A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.

  2001cited by this paper
• Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia.

  1999cited by this paper
• Ligand‐induced differentiation of glucocorticoid receptor (GR) trans‐repression and transactivation: preferential targetting of NF‐κB and lack of I‐κB involvement

  1999cited by this paper
• Modulation of hormone-dependent glucocorticoid receptor function using a tetracycline-regulated expression system.

  1998cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• Atomic structure of progesterone complexed with its receptor

  1998cited by this paper
• Systemic corticosteroid therapy—side effects and their management

  1998cited by this paper
• DNA binding of the glucocorticoid receptor is not essential for survival.

  1998cited by this paper
• Mometasone furoate. A review of its intranasal use in allergic rhinitis.

  1998cited by this paper
• Allosteric effects of DNA on transcriptional regulators

  1998cited by this paper
• Anti-inflammatory actions of glucocorticoids: molecular mechanisms.

  1998cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper
• Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement.

  1996cited by this paper
• A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP‐1.

  1994cited by this paper
• Glucocorticoid resistance in childhood leukemia.

  1994cited by this paper
• Structure of trypanothione reductase from Crithidia fasciculata at 2.6 A resolution; enzyme-NADP interactions at 2.8 A resolution.

  1994cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Non-glucocorticoid receptor-mediated effects of the potent glucocorticoid deacylcortivazol.

  1982cited by this paper
• Glucocorticoid hormone action.

  1976cited by this paper

• Synthesis and Molecular Docking study of Beclomethasone Dipropionate Derivatives as Glucocorticoid Receptor Inhibitors

  2025cites this paper
• Nuclear hormone receptors control fundamental processes of human fetal neurodevelopment: Basis for endocrine disruption assessment

  2025cites this paper
• Corticosteroid as Treatment in Infective Conjunctivitis: A Systematic Literature Review and Meta-Analysis

  2025cites this paper
• Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone loss

  2025cites this paper
• Computational and experimental insights into the interaction of the seaweed-derived steroidal metabolite 11α-hydroxyprogesterone with the glucocorticoid receptor

  2025cites this paper
• Differential Regulation of Cholecystokinin Production by Synthetic and Natural Glucocorticoids in Enteroendocrine Cells.

  2025cites this paper
• The multimerization pathway of the glucocorticoid receptor.

  2025cites this paper
• Comparative quantum chemical analysis of dexamethasone and hydrocortisone: electronic structure, and reactivity indices using DFT

  2025cites this paper
• Effects of glucocorticoid receptor activation on gene expression and antiviral responses in Atlantic salmon (Salmo salar L.) red blood cells

  2025cites this paper
• Study on the toxicity and in vitro and in vivo antidiabetic activities of Miliusa velutina stem bark ethanolic extract

  2025cites this paper
• Incorporation of Mometasone Furoate into a Cyclodextrin Metal-Organic Framework to Optimize Nasal Administration

  2025cites this paper
• Nuclear receptors in cancer: Unveiling theranostic potentials and innovative therapeutic strategies.

  2025cites this paper
• A “seed”-based molecular networking strategy for the screening and identification of unknown glucocorticoids in cosmetics

  2025cites this paper
• A novel mutation in the NR3C1 gene associated with reversible glucocorticoid resistance.

  2024cites this paper
• Nanotechnological approaches to improve corticosteroids ocular therapy.

  2024cites this paper
• Identification of Compounds Contributing to Glucocorticoid Activity in Indoor Dust Supported by Orthogonal Fractionation.

  2024cites this paper
• Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host.

  2024cites this paper
• Bilayered skin equivalent mimicking psoriasis as predictive tool for preclinical treatment studies

  2024cites this paper
• Accelerating reliable multiscale quantum refinement of protein–drug systems enabled by machine learning

  2024cites this paper
• Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host

  2024cites this paper
• Hypoglycemic Activity of Rice Resistant-Starch Metabolites: A Mechanistic Network Pharmacology and In Vitro Approach

  2024cites this paper
• First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of PA9159 Nasal Spray, a Highly Potent Glucocorticoid in Healthy Chinese Volunteers.

  2024cites this paper
• From Antibodies to Crystals: Understanding the Structure of the Glucocorticoid Receptor and Related Proteins

  2023influential citation
• Identification of an Evolutionarily Conserved Allosteric Network in Steroid Receptors

  2023cites this paper
• Biotransformation of Δ1-Progesterone Using Selected Entomopathogenic Filamentous Fungi and Prediction of Its Products’ Bioactivity

  2023cites this paper
• Glucocorticoids, Their Uses, Sexual Dimorphisms, and Diseases: New Concepts, Mechanisms, and Discoveries.

  2023cites this paper
• The Biologist’s Guide to the Glucocorticoid Receptor’s Structure

  2023influential citation
• Structure of Hsp90-p23-GR reveals the Hsp90 client-maturation mechanism

  2022cites this paper
• Dimerization of the Glucocorticoid Receptor and Its Importance in (Patho)physiology: A Primer

  2022cites this paper
• Conformational epistasis impairs AlphaFold structural predictions

  2022cites this paper
• Investigation of the Influence of Various Functional Groups on the Dynamics of Glucocorticoids

  2022cites this paper
• Green electrocatalytic Assembling of Salicylaldehydes, Kojic Acid, and Malonic Acid Derivatives into 2‐amino‐4H‐chromenes as Potent Anti‐inflammatory Agents

  2022cites this paper
• Chemically inducible split protein regulators for mammalian cells

  2022cites this paper
• Dexamethasone-Induced Adipose Tissue Redistribution and Metabolic Changes: Is Gene Expression the Main Factor? An Animal Model of Chronic Hypercortisolism

  2022cites this paper
• A Poly (Caprolactone)-Cellulose Nanocomposite Hydrogel for Transdermal Delivery of Hydrocortisone in Treating Psoriasis Vulgaris

  2022cites this paper
• Structural insights into glucocorticoid receptor function.

  2021cites this paper
• Deacylcortivazol-like pyrazole regioisomers reveal a more accommodating expanded binding pocket for the glucocorticoid receptor.

  2021cites this paper
• Structure of Hsp90–p23–GR reveals the Hsp90 client-remodelling mechanism

  2021cites this paper
• Steroids in Medicinal Chemistry: Literature Review

  2021cites this paper
• Caged Dexamethasone/Quercetin Nanoparticles, Formed of the Morphogenetic Active Inorganic Polyphosphate, are Strong Inducers of MUC5AC

  2021cites this paper
• Bone Marrow Homeostasis Is Impaired via JAK/STAT and Glucocorticoid Signaling in Cancer Cachexia Model

  2021cites this paper
• Biodegradable Electrospun Nanofibers: A New Approach For Rhinosinusitis Treatment.

  2021cites this paper
• The COVID‐19 vaccine and interventional procedures: Exploring the relationship between steroid administration and subsequent vaccine efficacy

  2021cites this paper
• Conserved functional motifs of the nuclear receptor superfamily as potential pharmacological targets

  2021cites this paper
• Drug repositioning to propose alternative modulators for glucocorticoid receptor through structure-based virtual screening

  2021cites this paper
• Molecular View on the Dissociation Pathways and Transactivation Regulation Mechanism of Nonsteroidal GR Ligands

  2021cites this paper
• The multivalency of the glucocorticoid receptor ligand-binding domain explains its manifold physiological activities

  2021cites this paper
• Chemoenzymatic and Enantiomeric Switching Regimes Enabling the Synthesis of Homochiral Cyclohexa-2,5-dienones Incorporating All-Carbon Quaternary Centers.

  2021cites this paper
• Budesonide In The First Line Treatment Of Patients With Autoimmune Hepatitis

  2021cites this paper
• Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions

  2021cites this paper
• Self-Assembling Derivative of Hydrocortisone as Glucocorticoid Receptor-Targeted Nanotherapeutics for Synergistic, Combination Therapy against Colorectal Tumor.

  2020cites this paper
• Crystal structure of the mineralocorticoid receptor ligand‐binding domain in complex with a potent and selective nonsteroidal blocker, esaxerenone (CS‐3150)

  2020cites this paper
• Úskalí celkové a lokální terapie kortikosteroidy

  2020cites this paper
• Pitfalls of systemic and local corticosteroid treatment

  2020cites this paper
• Dynamic allosteric communication pathway directing differential activation of the glucocorticoid receptor

  2020cites this paper
• Effect of exogenous glucocorticoids on male hypogonadism

  2020cites this paper
• Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives

  2020cites this paper
• Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment

  2020cites this paper
• Preparation and Evaluation of Cubosomes/Cubosomal Gels for Ocular Delivery of Beclomethasone Dipropionate for Management of Uveitis

  2020cites this paper
• Prolonged Glucocorticoid Exposure Does Not Accelerate Telomere Shortening in Cultured Human Fibroblasts

  2020cites this paper
• Dexamethasone Reduces Cell Adhesion and Migration of T47D Breast Cancer Cell Line.

  2020cites this paper
• Development of highly potent glucocorticoids for steroid-resistant severe asthma

  2019cites this paper
• Drug design strategies for Cushing’s syndrome

  2019cites this paper
• Induction of aortic valve calcification by celecoxib and its COX-2 independent derivatives is glucocorticoid-dependent.

  2019cites this paper
• Deciphering the structural basis for glucocorticoid resistance caused by missense mutations in the ligand binding domain of glucocorticoid receptor.

  2019cites this paper
• First High-Resolution Crystal Structures of the Glucocorticoid Receptor Ligand-Binding Domain–Peroxisome Proliferator-Activated γ Coactivator 1-α Complex with Endogenous and Synthetic Glucocorticoids

  2019influential citation
• GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life

  2019cites this paper
• Crystallographic Studies of Steroid-Protein Interactions.

  2019cites this paper
• Biosynthetic and Pharmacokinetic Approaches to Improve Steroid Therapeutics

  2019cites this paper
• Generalized Concentration Addition Model Predicts Glucocorticoid Activity Bioassay Responses to Environmentally Detected Receptor-Ligand Mixtures

  2018cites this paper
• Data on biosynthesis of BPAF glucuronide, enzyme kinetics of BPAF glucuronidation, and molecular modeling

  2018cites this paper
• Single Nucleotide Variations of the Human GR Gene Manifested as Pathologic Mutations or Polymorphisms.

  2018cites this paper
• The nuclear receptor superfamily: A structural perspective

  2018cites this paper
• Local delivery of mometasone furoate from an eluting endotracheal tube

  2018cites this paper
• Corticoids modulate liposome membrane fluidity and permeability depending on membrane composition and experimental protocol design.

  2018cites this paper
• Therapeutic Effect of a Novel Nano-Drug Delivery System on Membranous Glomerulonephritis Rat Model Induced by Cationic Bovine Serum

  2018cites this paper
• Alternative dimerization interfaces in the glucocorticoid receptor-α ligand binding domain.

  2018cites this paper
• Effect assessment of synthetic glucocorticoids to the selected freshwater invertebrate and vertebrate species

  2017cites this paper
• 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Evolution of the mineralocorticoid receptor: sequence, structure and function.

  2017cites this paper
• The Discovery of Potent and Selective Nonsteroidal Glucocorticoid Receptor Modulators AZD5423 and AZD7594, for the Inhaled Treatment of Respiratory Diseases

  2017cites this paper
• Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression

  2017cites this paper
• Synthesis of novel steroidal agonists, partial agonists, and antagonists for the glucocorticoid receptor.

  2017cites this paper
• How does stress affect human being—a molecular dynamic simulation study on cortisol and its glucocorticoid receptor

  2017cites this paper
• Evolution of the Mineralocorticoid Receptor: Sequence, Structure and Function

  2017influential citation
• Glucocorticoid receptor control of transcription: precision and plasticity via allostery

  2017cites this paper
• [What determines the effectiveness and safety of topical treatment of hemorrhoids].

  2017cites this paper
• Minna Kubin GLUCOCORTICOID RECEPTORS IN INFLAMMATORY SKIN DISEASES THE EFFECT OF SYSTEMIC AND TOPICAL GLUCOCORTICOID

  2016cites this paper
• Investigation on critical structural motifs of ligands for triggering glucocorticoid receptor nuclear migration through molecular docking simulations

  2016influential citation
• Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS).

  2016cites this paper
• Corticosteroids for Pain of Spinal Origin: Epidural and Intraarticular Administration.

  2016cites this paper
• Determination of endocrine disruption risk following exposure to betamethasone in surface and drinking water

  2016cites this paper
• The triterpene echinocystic acid and its 3-O-glucoside derivative are revealed as potent and selective glucocorticoid receptor agonists.

  2016cites this paper
• A Natural Mutation in Helix 5 of the Ligand Binding Domain of Glucocorticoid Receptor Enhances Receptor-Ligand Interaction

  2016cites this paper
• Glucocorticoid Receptor Structure and Function

  2015cites this paper
• Discovery of a highly potent glucocorticoid for asthma treatment

  2015cites this paper
• The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression

  2015cites this paper
• PHENOTYPIC PROFILING OF P53 WILDTYPE & MUTANT BREAST CANCER CELL LINES PHENOTYPIC AND CHEMOTHERAPY RESPONSE PROFILING OF P53 WILD- TYPE AND MUTANT HUMAN BREAST CANCER CELL LINES

  2015cites this paper
• Improving the pharmacokinetic and CYP inhibition profiles of azaxanthene-based glucocorticoid receptor modulators-identification of (S)-5-(2-(9-fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide

  2015cites this paper
• Canavanine induces insulin release via activation of imidazoline I3 receptors

  2015cites this paper
• UNIVERSIDADE FEDERAL DO MARANHÃO CENTRO DE CIÊNCIAS BIOLÓGICAS E DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA SAÚDE

  2015cites this paper